Daré Bioscience, Inc. (DARE)

Daré Bioscience Stock Forecast

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Daré Bioscience stock ranges from a low of $12 to a high of $36. The average analyst price target of $20.33 forecasts a 605.90% increase in the stock price over the next year.

Price Target: $20.33 (+605.90%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$20.33	$13	$36
Change	+316.67%	+605.90%	+351.39%	+1150.0%

* Price targets were last updated on Apr 1, 2025.

Analyst Ratings

The average analyst rating for Daré Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+316.67%	Apr 1, 2025
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+316.67%	Dec 17, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+316.67%	Nov 15, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+316.67%	Oct 24, 2024
Catherine Novack Jones Trading	Jones Trading	Strong Buy Maintains $5 → $13	Strong Buy	Maintains	$5 → $13	+351.39%	Aug 16, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.13M

Increased by 11,398.36%

from 9.78K

Revenue Next Year

21.47M

Increased by 1,808.62%

from 1.13M

EPS This Year

-2.06

from -0.48

EPS Next Year

-1.21

from -2.06

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	10.00M	2.81M	9.78K	1.13M	21.47M	71.58M
Revenue Growth	-	-	-	-71.92%	-99.65%	11,398.36%	1,808.62%	233.38%
EPS	-10.93	-7.59	-4.39	-4.15	-0.48	-2.06	-1.21	0.49
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	5.82
No. Analysts	-	-	-	-	-	6	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	3.5M	44.2M	102.6M
Avg	1.1M	21.5M	71.6M
Low	n/a	n/a	41.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	35,396.7%	3,829.4%	377.7%
Avg	11,398.4%	1,808.6%	233.4%
Low	-	-	94.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.53	-0.09	0.81
Avg	-2.06	-1.21	0.49
Low	-2.43	-2.23	0.20

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.